Maze Therapeutics Ownership | Who Owns Maze Therapeutics?
Maze Therapeutics Ownership Summary
Maze Therapeutics is owned by 100.93% institutional investors, 1.63% insiders. Frazier life sciences management is the largest institutional shareholder, holding 10.63% of MAZE shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.55% of its assets in Maze Therapeutics shares.
MAZE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Maze Therapeutics | 100.93% | 1.63% | -2.56% |
| Sector | Healthcare Stocks | 245.30% | 12.08% | -157.38% |
| Industry | Biotech Stocks | 381.70% | 11.71% | -293.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 4.57M | 10.63% | $136.33M |
| Trv gp iv | 4.47M | 10.41% | $133.55M |
| Arch venture management | 4.12M | 9.59% | $122.98M |
| Deep track capital, lp | 3.48M | 8.09% | $103.81M |
| Janus henderson group | 2.86M | 6.65% | $85.28M |
| Blackrock funding, inc. /de | 2.57M | 5.98% | $76.73M |
| Ah capital management | 1.70M | 3.96% | $50.81M |
| Vr adviser | 1.60M | 3.73% | $47.82M |
| Vanguard group | 1.70M | 3.71% | $70.31M |
| Alphabet | 1.39M | 3.23% | $41.45M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Trv gp iv | 4.47M | 50.04% | $133.55M |
| Arch venture management | 4.12M | 18.16% | $122.98M |
| General catalyst group management | 1.04M | 16.85% | $30.92M |
| Trv gp v | 950.80K | 7.08% | $28.38M |
| Ah capital management | 1.70M | 3.94% | $50.81M |
| Frazier life sciences management | 4.57M | 3.51% | $136.33M |
| Logos global management lp | 1.24M | 1.84% | $36.86M |
| Vr adviser | 1.60M | 1.78% | $47.82M |
| Casdin capital | 758.86K | 1.72% | $22.65M |
| Deep track capital, lp | 3.48M | 1.70% | $103.81M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 1.18M | 0.05% | 1.18M |
| Farallon capital management | 373.00K | 0.06% | 373.00K |
| Vanguard group | 1.70M | 0.00% | 362.06K |
| Citadel advisors | 775.71K | 0.00% | 327.50K |
| Logos global management lp | 1.24M | 1.84% | 285.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -2.74M |
| Bellevue group | - | - | -887.71K |
| Deep track capital, lp | 3.48M | 1.70% | -768.88K |
| Cormorant asset management, lp | - | - | -750.00K |
| Caligan partners lp | - | - | -614.96K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adage capital partners gp | 1.18M | 0.05% | 1.18M | $35.16M |
| Farallon capital management | 373.00K | 0.06% | 373.00K | $11.13M |
| Candriam s.c.a. | 278.17K | 0.04% | 278.17K | $8.30M |
| Abrdn | 226.23K | 0.01% | 226.23K | $6.75M |
| Vanguard fiduciary trust | 151.00K | 0.00% | 151.00K | $4.51M |
Sold Out
| Holder | Change |
|---|---|
| Hughes financial services | -1.00 |
| Stone house investment management | -2.00 |
| Quadrant capital group | -4.00 |
| Mai capital management | -5.00 |
| True wealth design | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 169 | -3.98% | 59,547,301 | 15.23% | 100 | 1.10% | 106 | -2.75% | 40 | 11.11% |
| Mar 31, 2026 | 57 | -60.42% | 10,759,374 | -77.75% | 25 | 0.22% | 36 | -65.71% | 9 | -55.00% |
| Dec 31, 2025 | 75 | -20.21% | 24,665,288 | -42.60% | 53 | 0.56% | 57 | -8.06% | 9 | -40.00% |
| Sep 30, 2025 | 49 | -33.78% | 17,110,255 | -55.94% | 39 | 0.50% | 34 | -19.05% | 7 | -46.15% |
| Jun 30, 2025 | 74 | 15.63% | 38,836,437 | 8.98% | 88 | 0.57% | 42 | -34.38% | 13 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 1.41M | 2.55% | 249.80K |
| Vanguard Total Stock Mkt Idx Inv | 1.41M | 2.55% | 249.80K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.41M | 2.54% | - |
| iShares Russell 2000 ETF | 913.80K | 1.65% | -10.56K |
| Fidelity Select Biotechnology | 787.46K | 1.42% | 5.00K |
| Janus Henderson Hrzn Biotec E2 USD | 692.97K | 1.25% | -2.59K |
| JPMorgan Small Cap Growth A | 535.72K | 0.96% | -15.80K |
| Fidelity Small Cap Index | 385.64K | 0.69% | 2.81K |
| State Street® SPDR® S&P® PhrmctlsETF | 376.97K | 0.68% | -4.68K |
| Eventide Healthcare & Life Sciences I | 324.04K | 0.65% | 324.04K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 01, 2026 | Coloma Jason V | Chief Executive Officer | Sell | $862.19K |
| Oct 01, 2026 | Coloma Jason V | Chief Executive Officer | Sell | $70.07K |
| Oct 01, 2026 | Bernstein Harold | President, R&D & CMO | Sell | $434.74K |
| Sep 29, 2026 | Dandekar Atul | CSBO | Sell | $202.92K |
| Sep 04, 2026 | Bernstein Harold | President, R&D & CMO | Sell | $254.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 3 |
| 2026 Q3 | - | 34 |
| 2026 Q2 | - | 21 |
| 2026 Q1 | - | 25 |
| 2025 Q4 | - | 8 |
MAZE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools